血管移植の世界市場

血管移植の世界市場は2030年までに59億米ドルに到達

2024年に39億米ドルと推定される血管移植の世界市場は、分析期間2024-2030年にCAGR 7.2％で成長し、2030年には59億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである血管内動脈瘤修復（EVAR）適応症は、CAGR 6.9％を記録し、分析期間終了までに26億米ドルに達すると予測されます。末梢血管修復の適応症セグメントの成長率は、分析期間中CAGR 8.7%と推定されます。

米国市場は15億米ドルと推定、中国はCAGR 8.9％で成長予測

米国の血管移植市場は2024年に15億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを8.9%として、2030年までに6億8,760万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.5％と6.4％と予測されています。欧州では、ドイツがCAGR約7.1%で成長すると予測されています。

世界の血管移植市場- 主要動向と促進要因のまとめ

血管移植とは何か、なぜ現代医療において重要なのか？

血管移植は、動脈硬化、動脈瘤、閉塞などの疾患によって必要となる、体内の血管の一部を置換、修復、バイパスするために使用される医療機器です。これらの移植片は、心臓への血流を改善する冠動脈バイパス移植術などの心臓血管手術において極めて重要です。これらの移植片に使用される材料は、人体との適合性、柔軟性や耐久性などの機械的特性に基づいて特別に選択されます。血管移植は、ポリエステルやポリテトラフルオロエチレン（PTFE）のような合成材料から作られることもあれば、ヒトや動物の組織を改良した生物学的材料から作られることもあります。

技術革新は血管移植技術をどのように向上させたか？

最近の血管移植技術の革新は、血管手術の結果を著しく改善しました。細胞の増殖と再生を促進する組織工学的移植片の開発は、この分野の進歩の一例です。これらの移植片は生体適合性に優れ、移植片の内面に新しい内皮細胞を増殖させる内皮化を促すように設計されており、それによって血栓症のリスクを軽減し、移植片の長期的な開存性を確保しています。さらに、画像診断技術の進歩により、移植片の設置精度が向上し、手術中のリスクや合併症の可能性が最小限に抑えられています。感染や再狭窄の予防に役立つ薬剤溶出性グラフトのような技術革新は、血管インターベンションの有効性と安全性をさらに高めています。

血管移植は血管疾患の治療においてどのような役割を果たしますか？

血管移植は、放置しておくと重篤な合併症を引き起こし、死に至ることさえある様々な血管疾患の治療において、欠くことのできない役割を果たしています。冠動脈疾患の患者さんには、血管移植を使用して詰まった動脈をバイパスし、心臓への正常な血流を回復させます。末梢動脈疾患を患っている患者には、これらの移植片が足の病気の動脈をバイパスし、痛みやけいれんなどの症状を緩和し、手足の切断を防ぐことができます。動脈瘤、特に腹部大動脈瘤の場合、移植片は破裂を防ぐために弱い動脈壁を補強します。血管移植の多用途性と適応性により、血管外科手術に不可欠なツールとなっており、リスクの高い患者に救命治療を提供しています。

血管移植市場の成長はいくつかの要因によってもたらされる

血管移植市場の成長は、人口の高齢化や糖尿病、肥満、高血圧などの危険因子の増加による世界の心血管疾患の有病率の増加など、いくつかの要因によって牽引されています。移植片の機能性と患者の適合性を向上させる技術の進歩も、この市場の拡大に寄与しています。回復時間を短縮し、患者の予後を改善する、より小さく、より高度な移植片を利用する低侵襲手術への嗜好が高まっています。さらに、新興国におけるヘルスケア支出の増加と、より洗練された医療施設の利用可能性が、血管移植手術へのアクセスを拡大しています。心血管系疾患の早期診断と早期治療の利点に関する一般市民の意識の高まりは、市場成長をさらに刺激し、現代の医療行為における血管移植の重要性を強調しています。

セグメント

適応症（血管内動脈瘤修復術（EVAR）、末梢血管修復術、血液透析アクセス）;原材料（ポリエステル、ePTFE、ポリウレタン、生体合成）;最終用途（病院、外来手術センター）

調査対象企業の例（注目の44社）

• Cardinal Health, Inc.
• Baxter International, Inc.
• Terumo Corporation
• Cook Medical, LLC
• Teleflex, Inc.
• LeMaitre Vascular, Inc.
• MicroPort Scientific Corporation
• iVascular S.L.U
• Jotec GmbH
• ParaGen Technologies
• sunnatech scientific corporation
• Vacis
• Cardiovascular Systems, Inc.
• Healionics
• InnAVasc Medical

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Vascular Grafts Market to Reach US$5.9 Billion by 2030

The global market for Vascular Grafts estimated at US$3.9 Billion in the year 2024, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Endovascular Aneurysm Repair (EVAR) Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Peripheral Vascular Repair Indication segment is estimated at 8.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 8.9% CAGR

The Vascular Grafts market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$687.6 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

Global Vascular Grafts Market - Key Trends & Drivers Summarized

What Are Vascular Grafts, and Why Are They Critical in Modern Medicine?

Vascular grafts are medical devices used to replace, repair, or bypass sections of blood vessels in the body, often necessitated by diseases such as atherosclerosis, aneurysms, or blockages. These grafts are crucial in cardiovascular surgeries, including coronary artery bypass grafting, which helps improve blood flow to the heart. The materials used for these grafts are specifically chosen based on their compatibility with the human body and their mechanical properties, such as flexibility and durability. Vascular grafts can be made from synthetic materials like polyester and polytetrafluoroethylene (PTFE), or from biological materials, including modified human or animal tissue.

How Have Innovations Enhanced Vascular Graft Technology?

Recent innovations in vascular graft technology have significantly improved the outcomes of vascular surgeries. The development of tissue-engineering grafts, which promote cell growth and regeneration, is one example of how this field is advancing. These grafts are designed to be biocompatible and to encourage endothelialization, where new endothelial cells grow on the inner surface of the graft, thereby reducing the risk of thrombosis and ensuring the long-term patency of the graft. Additionally, advancements in imaging and diagnostic technologies have improved the precision of graft placement, minimizing risks and potential complications during surgeries. Innovations like drug-eluting grafts that help prevent infection and restenosis further enhance the efficacy and safety of vascular interventions.

What Role Do Vascular Grafts Play in Treating Vascular Diseases?

Vascular grafts play an indispensable role in the treatment of a range of vascular diseases that can lead to severe complications and even death if left untreated. In patients with coronary artery disease, vascular grafts are used to bypass clogged arteries, helping to restore normal blood flow to the heart. For individuals suffering from peripheral arterial disease, these grafts can bypass diseased arteries in the legs, alleviating symptoms like pain and cramps and preventing limb amputation. In cases of aneurysms, particularly abdominal aortic aneurysms, grafts reinforce weak arterial walls to prevent rupture. The versatility and adaptability of vascular grafts make them essential tools in vascular surgery, providing life-saving treatments for high-risk patients.

Growth in the Vascular Grafts Market Is Driven by Several Factors

The growth in the vascular grafts market is driven by several factors, including the increasing prevalence of cardiovascular diseases globally due to aging populations and rising risk factors such as diabetes, obesity, and hypertension. Technological advancements that improve graft functionality and patient compatibility also contribute to the expansion of this market. There is a growing preference for minimally invasive surgeries, which utilize smaller, more advanced grafts that reduce recovery time and improve patient outcomes. Additionally, the rise in healthcare expenditure and the availability of more sophisticated healthcare facilities in emerging economies are expanding access to vascular graft procedures. Enhanced public awareness about the benefits of early diagnosis and treatment of cardiovascular conditions further stimulates market growth, underscoring the critical nature of vascular grafts in contemporary medical practices.

SCOPE OF STUDY:

The report analyzes the Vascular Grafts market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair, Hemodialysis Access); Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic); End-Use (Hospitals, Ambulatory Surgical Centers)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 44 Featured) -

• Cardinal Health, Inc.
• Baxter International, Inc.
• Terumo Corporation
• Cook Medical, LLC
• Teleflex, Inc.
• LeMaitre Vascular, Inc.
• MicroPort Scientific Corporation
• iVascular S.L.U
• Jotec GmbH
• ParaGen Technologies
• sunnatech scientific corporation
• Vacis
• Cardiovascular Systems, Inc.
• Healionics
• InnAVasc Medical

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Vascular Grafts - Global Key Competitors Percentage Market Share in 2024 (E)
  • A Prelude to Vascular Grafting
  • Global Market Prospects and Overview
  • Vascular Grafts Market Set for a Rapid Growth
  • Endovascular Stent-Grafts Account for Larger Share
  • Competition
  • Recent Market Activity
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Incidence of Cardio Vascular Disease Bodes Well for the Global Vascular Graft Market
  • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
  • Rising Preference for Minimally Invasive Procedures Boosts Market Prospects
  • Rising Prevalence of Kidney Diseases Drives the Global Hemodialysis Vascular Graft Market
  • Hemodialysis Remains the Major Modality for Dialysis Treatment - A Key Opportunity
  • Global Dialysis Patient Population Distribution by Modality for Select Countries (2020): Percentage Breakdown of Hemodialysis (HD) and Peritoneal Dialysis (PD) Patients
  • Global Population of ESRD Patients Undergoing Therapy by Type of Treatment (2020): Percentage Breakdown of Patients Receiving Hemodialysis, Kidney Transplants, and Peritoneal Dialysis
  • Home Hemodialysis: A Niche Albeit High Potential Market
  • World Dialysis Clinics Market by Region (2019): Percentage Breakdown of Patients Treated by Type of Operator
  • Global Dialysis Market by Region: Percentage Breakdown of Patients Receiving Dialysis Treatment in In-Centre and Home Settings for 2019
  • Aging Population Drives Demand for Vascular Grafts
  • Increasing Healthcare Expenditure to Foster Growth
  • World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018
  • Rising Middle Class Population Aids Growth
  • Global Middle Class Population (in Millions) and as a Percentage of Total Population: 2005, 2015, 2025 & 2035
  • Global Middle Class Spending (in US$ Trillion) by Geographic Region
  • Risk of CAD in Obesity Offers Prospects for Coronary Stenting
  • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
  • Cell-Free Tissue Engineered Vascular Grafts Aid in Vascular Remodeling
  • New Approach for Optimizing TEVGs
  • 3D Printed Vascular Scaffolds Hold Potential to be the New-Age TEVGs
  • A Review of Select Vascular Developments
  • Some of the important vascular innovations expected in the near-term include:
  • Offerings of Moving Analytics and Vasctrac
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair (EVAR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Endovascular Aneurysm Repair (EVAR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Endovascular Aneurysm Repair (EVAR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Peripheral Vascular Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Peripheral Vascular Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Peripheral Vascular Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Hemodialysis Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Hemodialysis Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Hemodialysis Access by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Polyester by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Polyester by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Polyester by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for ePTFE by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Polyurethane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Biosynthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Biosynthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Biosynthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Vascular Grafts Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Vascular Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• JAPAN
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• CHINA
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• EUROPE
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Vascular Grafts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
• FRANCE
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• GERMANY
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Vascular Grafts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
• AUSTRALIA
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• INDIA
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Vascular Grafts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Vascular Grafts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
• AFRICA
  • Vascular Grafts Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030

IV. COMPETITION